Industry News
Protein Strongest Just Before Death
Dec 18, 2012
Researchers at Michigan State University have discovered a protein that does its best work with one foot in the grave. The study, which appears in the Journal of Biological Chemistry, focuses on the nontraditional lifestyle of Retinoblastoma tumor suppressor proteins, which could lead to new ways to treat cancer... Read More
Surprising Discovery About Stem Cells Reveals How A Common Breast Cancer Evades Treatment
Dec 17, 2012
A new study reveals a surprising paradox about stem cells in breast cancer: one whose discovery may explain how a common breast cancer evades treatment, and improve diagnosis and treatment of the disease... Read More
Ruxolitinib Produces Durable Improvements In Patients With Myelofibrosis
Dec 17, 2012
ATLANTA - Ruxolitinib reduces splenomegaly and other symptoms commonly associated with myelofibrosis, and the results are maintained for at least two years, according to results released at the 54th American Society of Hematology Annual Meeting... Read More
The Age Of Chronic Leukemia Patients May Affect Therapy
Dec 17, 2012
Doctors should use different therapies when treating older and younger patients with chronic lymphocytic leukemia, according to a new study led by researchers at the Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James)... Read More
Patients With Non-Small Cell Lung Carcinoma Most Likely To Benefit From ALK Inhibition Therapy Identified By Novel Test
Dec 17, 2012
Approximately one in 20 patients with non-small cell lung carcinoma (NSCLC) has chromosomal aberrations targeting the anaplastic lymphoma kinase (ALK) gene. This has considerable implications for treatment because these patients are highly responsive to ALK-specific kinase inhibitors such as crizotinib. However, current diagnostic tests have limitations... Read More
Family History Of Colorectal Cancer May Increase Risk For Aggressive Form Of The Disease
Dec 17, 2012
When people with a family history of colorectal cancer develop the disease, their tumors often carry a molecular sign that the cancer could be life-threatening and may require aggressive treatment, Dana-Farber Cancer Institute scientists report in a new study... Read More
Drug Approved To Treat Rare Forms Of Leukemia
Dec 17, 2012
A new drug used to treat patients with chronic myeloid leukemia (CML) and Philadelphia chromosome positive acute leukemia (Ph+ ALL) has just received approval from the U.S. Food and Drug Administration... Read More
Younger Women May Be Able To Reduce The Risk Of An Aggressive Form Of Breast Cancer By Delaying Childbirth
Dec 17, 2012
Younger women who wait at least 15 years after their first menstrual period to give birth to their first child may reduce their risk of an aggressive form of breast cancer by up to 60 percent, according to a Fred Hutchinson Cancer Research Center study. The findings, by Christopher I. Li, M.D., Ph.D... Read More
Common Childhood Leukemia May Be Treated With Vegetable Compound
Dec 17, 2012
It looks like your mother was on to something when she said, "Eat your vegetables!" A concentrated form of a compound called sulforaphane found in broccoli and other cruciferous vegetables has been shown to reduce the number of acute lymphoblastic leukemia cells in the lab setting, said researchers at Baylor College of Medicine. The findings appear in PLOS ONE... Read More
Synthetic Chemistry And Drug Development
Dec 17, 2012
In science's equivalent of ascending Mt. Everest, researchers are reporting success in one of the most difficult challenges in synthetic chemistry - a field in which scientists reproduce natural and other substances from jars of chemicals in a lab... Read More
Previous Page Next Page